GP-2.2

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGP-2.2

Drug Alias NameBGP-mAb1anti-BGP1 mAbs (GenPat77)anti-carcinoembryonic antigen-related cell adhesion molecule 1 mAbs (GenPat77)monoclonal antibody CD66a inhibitors (GenPat77)monoclonal antibody CEACAM1 inhibitors (GenPat77) +[8]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 1 inhibitors

TargetsCarcinoembryonic antigen related cell adhesion molecule 1

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenPat77 Pharmacogenetics AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenPat77 Pharmacogenetics AG

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A